These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12450631)

  • 21. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nongenomic steroidal modulation of high-affinity serotonin transport.
    Chang AS; Chang SM
    Biochim Biophys Acta; 1999 Feb; 1417(1):157-66. PubMed ID: 10076044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
    Watanabe Y; Sakai RR; McEwen BS; Mendelson S
    Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain.
    Bal N; Figueras G; Vilaró MT; Suñol C; Artigas F
    Eur J Neurosci; 1997 Aug; 9(8):1728-38. PubMed ID: 9283827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin 5- HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors.
    López-Giménez JF; Tecott LH; Palacios JM; Mengod G; Vilaró MT
    J Neurosci Res; 2002 Jan; 67(1):69-85. PubMed ID: 11754082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
    Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
    Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
    Siebert GA; Pond SM; Bryan-Lluka LJ
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):255-64. PubMed ID: 10731037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotonin regulates osteoclast differentiation through its transporter.
    Battaglino R; Fu J; Späte U; Ersoy U; Joe M; Sedaghat L; Stashenko P
    J Bone Miner Res; 2004 Sep; 19(9):1420-31. PubMed ID: 15312242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin metabolism in rat mesangial cells: involvement of a serotonin transporter and monoamine oxidase A.
    Pizzinat N; Girolami JP; Parini A; Pecher C; Ordener C
    Kidney Int; 1999 Oct; 56(4):1391-9. PubMed ID: 10504491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist properties.
    Pullar IA; Boot JR; Carney SL; Cohen ML; Colvin EM; Conway RG; Hardy CH; Lucaites VL; Nelson DL; Schenck KW; Tomlinson R; Wedley S
    Eur J Pharmacol; 2001 Nov; 432(1):9-17. PubMed ID: 11734182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
    Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
    J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proposed pathological model in the hippocampus of subjects with schizophrenia.
    Scarr E; Copolov DL; Dean B
    Clin Exp Pharmacol Physiol; 2001; 28(1-2):70-3. PubMed ID: 11153541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampal serotonin depletion facilitates the enhancement of prepulse inhibition by risperidone: possible role of 5-HT(2C) receptors in the dorsal hippocampus.
    Adams W; van den Buuse M
    Neuropharmacology; 2011 Sep; 61(3):458-67. PubMed ID: 21477601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous 5-HT, released by MDMA through serotonin transporter- and secretory vesicle-dependent mechanisms, reduces hippocampal excitatory synaptic transmission by preferential activation of 5-HT1B receptors located on CA1 pyramidal neurons.
    Mlinar B; Corradetti R
    Eur J Neurosci; 2003 Sep; 18(6):1559-71. PubMed ID: 14511335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine.
    Yoshimura R; Yanagihara N; Hara K; Nakamura J; Toyohira Y; Ueno S; Izumi F
    J Neurochem; 2001 May; 77(4):1018-26. PubMed ID: 11359867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.
    Enguix MJ; Sánchez L; Villazón M; Brea J; Tristán H; Caruncho HJ; Cadavid MI; Loza MI
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):79-90. PubMed ID: 12861437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effects of clozapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells.
    Yoshimura R; Yanagihara N; Hara K; Terao T; Nakamura J; Ueno S; Toyohira Y; Uezono Y; Kaneko S; Kawamura M; Abe K; Izumi F
    Psychopharmacology (Berl); 2000 Mar; 149(1):17-23. PubMed ID: 10789878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.
    Cussac D; Duqueyroix D; Newman-Tancredi A; Millan MJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):168-77. PubMed ID: 12110994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium-dependent inhibition of synaptosomal serotonin transport by the alpha 2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304).
    Ansah TA; Ramamoorthy S; Montañez S; Daws LC; Blakely RD
    J Pharmacol Exp Ther; 2003 Jun; 305(3):956-65. PubMed ID: 12626658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.